Not applicableEnded earlyNCT01737957What this trial is testingSafety and Efficacy of Low-Fluence PRP for PDRWho this might be right forProliferative Diabetic Retinopathy Asociación para Evitar la Ceguera en México 60
Not applicableUnknownNCT05938491What this trial is testingOCT and OCT-A Afer Diabetic Vitrectomy in PDRWho this might be right forProliferative Diabetic Retinopathy Assiut University 30
Testing effectiveness (Phase 2)UnknownNCT00931125What this trial is testingSafety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy AloneWho this might be right forDiabetic Retinopathy Attila Vajas 70
Not applicableStudy completedNCT01270542What this trial is testingAvastin for PDR (Proliferative Diabetic Retinopathy)Who this might be right forRetinal DetachmentDiabetic Retinopathy University of Southern California 20
Not applicableStudy completedNCT03904056What this trial is testingETDRS PRP With IVR Versus Retinal Photocoagulation Targeted to Ischemic Retina With IVR for the Treatment of PDRWho this might be right forDiabetic Retinopathy São Paulo State University 23
Post-approval studies (Phase 4)UnknownNCT03506750What this trial is testingDay Regimes of CONbercept on CytokinEs of PDR Patients Undergoing Vitrectomy - Trial (CONCEPT)Who this might be right forProliferative Diabetic RetinopathyVEGF Overexpression The First Affiliated Hospital with Nanjing Medical University 200
Large-scale testing (Phase 3)Looking for participantsNCT06790784What this trial is testingFaricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDRWho this might be right forProliferative Diabetic Retinopathy (PDR) Jaeb Center for Health Research 426
Not applicableStudy completedNCT04018326What this trial is testingLoss to Follow-up in PDR PatientsWho this might be right forDiabetic Retinopathy Assiut University 467
Not applicableUnknownNCT04000789What this trial is testingThe Effect of Combination of Vitamin A, Vitamin E, Sodium Hyaluronate 0.15% Eye Drop Compared With Sodium Hyaluronate 0.1% Eye Drop to Tear Film Stability and Conjunctival Goblet Cells Density in Patient With Non-Proliferative Diabetic Retinopathy (NPDR), and Proliferative Diabetic Retinopathy (PDR)Who this might be right forNon-Proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy New Vessels on DiscDry Eye Syndromes Dr Cipto Mangunkusumo General Hospital 96
Early research (Phase 1)Study completedNCT01487070What this trial is testingA Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic RetinopathyWho this might be right forPDR Retina Institute of Hawaii 5
Not applicableStudy completedNCT01760746What this trial is testingComparison of Changes of Inflammatory Proteins in Aqueous Humour of Subjects Treated With Avastin vs LucentisWho this might be right forProliferative Diabetic Retinopathy (PDR) University of British Columbia 30
Large-scale testing (Phase 3)Ended earlyNCT00248157What this trial is testingExtension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic RetinopathyWho this might be right forDiabetic Retinopathy Novartis Pharmaceuticals 105
Large-scale testing (Phase 3)UnknownNCT02447185What this trial is testing25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical TrialWho this might be right forProliferative Diabetic Retinopathy JUNYAN ZHANG 200
Testing effectiveness (Phase 2)Study completedNCT01281098What this trial is testingProspective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.Who this might be right forHigh Risk Proliferative Diabetic RetinopathyDiabetes Mellitus Type IDiabetes Mellitus Type II Association for Innovation and Biomedical Research on Light and Image 22
Testing effectiveness (Phase 2)UnknownNCT05642793What this trial is testingEffect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR PatientsWho this might be right forProliferative Diabetic Retinopathy Peking University Third Hospital 80
Not applicableUnknownNCT05415826What this trial is testingOzurdex in Reducing PVR After Vitreotomy in PDRWho this might be right forDiabetic Retinopathy Peking University People's Hospital 30
Large-scale testing (Phase 3)WithdrawnNCT01589718What this trial is testingThe Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic RetinopathyWho this might be right forProliferative Diabetic Retinopathy Greater Houston Retina Research
Not applicableUnknownNCT00403026What this trial is testingIntravitreal Bevacizumab for Retinal DisordersWho this might be right forWet AMDMacular OedemaProliferative Diabetic Retinopathy Narayana Nethralaya 150
Not applicableNot Yet RecruitingNCT07315802What this trial is testingNew Pattern of Retinal Laser Treatment for PDRWho this might be right forProliferative Diabetic RetinopathyPhotocoagulation Burn to Retina Eye & ENT Hospital of Fudan University 300
Not applicableUnknownNCT05838898What this trial is testingSpecular Microscopy in Patients With Proliferative Diabetic RetinopathyWho this might be right forCorneal Endothelial Cell Changes in Diabetic Patients Assiut University 60